These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2557383)

  • 1. Passive protection of mice, goats, and monkeys against Japanese encephalitis with monoclonal antibodies.
    Zhang MJ; Wang MJ; Jiang SZ; Ma WY
    J Med Virol; 1989 Oct; 29(2):133-8. PubMed ID: 2557383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and characterization of the monoclonal antibodies against Japanese encephalitis virus.
    Zhang MJ; Wang MX; Jiang SZ; Xiu ZZ; Ma WY
    Acta Virol; 1992 Dec; 36(6):533-40. PubMed ID: 1284867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humanized monoclonal antibodies derived from chimpanzee Fabs protect against Japanese encephalitis virus in vitro and in vivo.
    Goncalvez AP; Chien CH; Tubthong K; Gorshkova I; Roll C; Donau O; Schuck P; Yoksan S; Wang SD; Purcell RH; Lai CJ
    J Virol; 2008 Jul; 82(14):7009-21. PubMed ID: 18480437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies.
    Kimura-Kuroda J; Yasui K
    J Immunol; 1988 Nov; 141(10):3606-10. PubMed ID: 2460542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, immunogenicity, and protective efficacy of NYVAC-JEV and ALVAC-JEV recombinant Japanese encephalitis vaccines in rhesus monkeys.
    Raengsakulrach B; Nisalak A; Gettayacamin M; Thirawuth V; Young GD; Myint KS; Ferguson LM; Hoke CH; Innis BL; Vaughn DW
    Am J Trop Med Hyg; 1999 Mar; 60(3):343-9. PubMed ID: 10466959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for neutralization of Japanese encephalitis virus by two potent therapeutic antibodies.
    Qiu X; Lei Y; Yang P; Gao Q; Wang N; Cao L; Yuan S; Huang X; Deng Y; Ma W; Ding T; Zhang F; Wu X; Hu J; Liu SL; Qin C; Wang X; Xu Z; Rao Z
    Nat Microbiol; 2018 Mar; 3(3):287-294. PubMed ID: 29379207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of human Fab (gamma1/kappa) library and identification of human monoclonal Fab possessing neutralizing potency against Japanese encephalitis virus.
    Arakawa M; Yamashiro T; Uechi G; Tadano M; Nishizono A
    Microbiol Immunol; 2007; 51(6):617-25. PubMed ID: 17579273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO(®)) induced neutralizing antibody titers.
    Van Gessel Y; Klade CS; Putnak R; Formica A; Krasaesub S; Spruth M; Cena B; Tungtaeng A; Gettayacamin M; Dewasthaly S
    Vaccine; 2011 Aug; 29(35):5925-31. PubMed ID: 21723353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An intranasal challenge model for testing Japanese encephalitis vaccines in rhesus monkeys.
    Raengsakulrach B; Nisalak A; Gettayacamin M; Thirawuth V; Young GD; Myint KS; Ferguson LM; Hoke CH; Innis BL; Vaughn DW
    Am J Trop Med Hyg; 1999 Mar; 60(3):329-37. PubMed ID: 10466957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Japanese encephalitis virus DNA vaccine candidates in rhesus monkeys [Macaca mulatta].
    Bharati K; Rani R; Vrati S
    Vaccine; 2009 Jan; 27(1):10-6. PubMed ID: 18996161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
    Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
    Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of cross-protection against two wild-type Taiwanese isolates of Japanese encephalitis virus using Beijing-1 strain DNA vaccine.
    Wu CJ; Huang HW; Tao MH
    Vaccine; 2003 Sep; 21(25-26):3938-45. PubMed ID: 12922129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low Protective Efficacy of the Current Japanese Encephalitis Vaccine against the Emerging Genotype 5 Japanese Encephalitis Virus.
    Cao L; Fu S; Gao X; Li M; Cui S; Li X; Cao Y; Lei W; Lu Z; He Y; Wang H; Yan J; Gao GF; Liang G
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004686. PubMed ID: 27139722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine.
    Beasley DW; Li L; Suderman MT; Guirakhoo F; Trent DW; Monath TP; Shope RE; Barrett AD
    Vaccine; 2004 Sep; 22(27-28):3722-6. PubMed ID: 15315852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccines.
    Markoff L
    Vaccine; 2000 May; 18 Suppl 2():26-32. PubMed ID: 10821970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced immune responses against Japanese encephalitis virus using recombinant adenoviruses coexpressing Japanese encephalitis virus envelope and porcine interleukin-6 proteins in mice.
    Liu H; Wu R; Liu K; Yuan L; Huang X; Wen Y; Ma X; Yan Q; Zhao Q; Wen X; Cao S
    Virus Res; 2016 Aug; 222():34-40. PubMed ID: 27235810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sub-fragments of the envelope gene are highly protective against the Japanese encephalitis virus lethal infection in DNA priming--protein boosting immunization strategies.
    Wu HH; Chen CT; Lin YL; Lee ST
    Vaccine; 2004 Jan; 22(5-6):793-800. PubMed ID: 14741175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased immunogenicity and protective efficacy in outbred and inbred mice by strategic carboxyl-terminal truncation of Japanese encephalitis virus envelope glycoprotein.
    Jan LR; Yang CS; Henchal LS; Sumiyoshi H; Summers PL; Dubois DR; Lai CJ
    Am J Trop Med Hyg; 1993 Mar; 48(3):412-23. PubMed ID: 8385887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with recombinant adenovirus synthesizing the secretory form of Japanese encephalitis virus envelope protein protects adenovirus-exposed mice against lethal encephalitis.
    Appaiahgari MB; Saini M; Rauthan M; Jyoti ; Vrati S
    Microbes Infect; 2006 Jan; 8(1):92-104. PubMed ID: 16126425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and characterization of a Fab recombinant protein for Japanese encephalitis virus neutralization.
    Wu SC; Lin YJ; Chou JW; Lin CW
    Vaccine; 2004 Nov; 23(2):163-71. PubMed ID: 15531033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.